)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
CHINA NATIONAL MEDICINES CORP
CHINA NATIONAL MEDICINES CORP (600511) investor relations material
CHINA NATIONAL MEDICINES CORP Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary20 Oct, 2026
Executive summary
Q3 2026 revenue was RMB 13.878bn, up 0.95% YoY; net income attributable to shareholders was RMB 596.5m, up 9.70%.
For 9M 2026, revenue rose 3.11% YoY to RMB 40.606bn, while attributable net income fell 1.07% to RMB 1.476bn.
Financial highlights
Q3 profit before tax was RMB 765.4m, up 8.24% YoY; adjusted attributable net income was RMB 595.7m, up 10.59%.
9M profit before tax declined 1.32% YoY to RMB 1.908bn; adjusted attributable net income edged up 0.36% to RMB 1.475bn.
9M consolidated net income was RMB 1.490bn versus RMB 1.556bn a year earlier; operating revenue was RMB 40.606bn versus RMB 39.381bn.
9M investment income was RMB 424.5m, including RMB 394.2m from associates and joint ventures, versus RMB 441.0m and RMB 411.1m, respectively, a year earlier.
Key financial ratios and metrics
Q3 basic and diluted EPS were RMB 0.7906, up 9.71% YoY; 9M EPS was RMB 1.9566, down 1.07%.
Weighted average ROE was 3.12% for Q3, up 0.06 percentage points YoY, and 7.79% for 9M, down 0.71 percentage points.
Total assets were RMB 36.813bn at Sep. 30, 2026, up 0.35% from year-end 2025; equity attributable to shareholders was RMB 19.408bn.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CHINA NATIONAL MEDICINES CORP
- Revenue up 4.27% YoY, but net profit down 7.25% amid margin pressure and policy headwinds.600511
Q2 2026 - Revenue and net profit rose year-over-year, but operating cash flow remained negative.600511Q1 2026
- Q3 profit and EPS rose over 13% year-over-year, but operating cash flow stayed negative.600511Q3 2025
- Revenue up 3.54% but net profit down 5.19% amid industry reform and strong distribution.600511Q2 2025
- Revenue and net profit rose modestly, but operating cash flow turned negative.600511Q3 2024
- Revenue and net profit grew modestly, with stable distribution but industrial headwinds.600511Q2 2024
- Revenue up 4.87% in Q1 2025, but net profit and ROE slightly declined.600511Q1 2025
- Revenue up 1.81%, net profit down 6.80%, with strong market share and digital transformation.600511Q4 2024
Next CHINA NATIONAL MEDICINES CORP earnings date
Q4 202619 Mar, 2027
CHINA NATIONAL MEDICINES CORP
Next CHINA NATIONAL MEDICINES CORP earnings date
Q4 202619 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)